Literature DB >> 16177119

Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins.

Tom W L Groeneveld1, Melinda Oroszlán, Rick T Owens, Maria C Faber-Krol, Astrid C Bakker, Gérard J Arlaud, David J McQuillan, Uday Kishore, Mohamed R Daha, Anja Roos.   

Abstract

Decorin and biglycan are closely related abundant extracellular matrix proteoglycans that have been shown to bind to C1q. Given the overall structural similarities between C1q and mannose-binding lectin (MBL), the two key recognition molecules of the classical and the lectin complement pathways, respectively, we have examined functional consequences of the interaction of C1q and MBL with decorin and biglycan. Recombinant forms of human decorin and biglycan bound C1q via both collagen and globular domains and inhibited the classical pathway. Decorin also bound C1 without activating complement. Furthermore, decorin and biglycan bound efficiently to MBL, but only biglycan could inhibit activation of the lectin pathway. Other members of the collectin family, including human surfactant protein D, bovine collectin-43, and conglutinin also showed binding to decorin and biglycan. Decorin and biglycan strongly inhibited C1q binding to human endothelial cells and U937 cells, and biglycan suppressed C1q-induced MCP-1 and IL-8 production by human endothelial cells. In conclusion, decorin and biglycan act as inhibitors of activation of the complement cascade, cellular interactions, and proinflammatory cytokine production mediated by C1q. These two proteoglycans are likely to down-regulate proinflammatory effects mediated by C1q, and possibly also the collectins, at the tissue level.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177119     DOI: 10.4049/jimmunol.175.7.4715

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  Complement in the immunopathogenesis of rheumatic disease.

Authors:  Gunnar Sturfelt; Lennart Truedsson
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

2.  Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis.

Authors:  Kaisa E Happonen; Tore Saxne; Anders Aspberg; Matthias Mörgelin; Dick Heinegård; Anna M Blom
Journal:  Arthritis Rheum       Date:  2010-12

Review 3.  Fell-Muir Lecture: Proteoglycans and more--from molecules to biology.

Authors:  Dick Heinegård
Journal:  Int J Exp Pathol       Date:  2009-12       Impact factor: 1.925

4.  Expression of mesenchyme-specific gene signatures by follicular dendritic cells: insights from the meta-analysis of microarray data from multiple mouse cell populations.

Authors:  Neil A Mabbott; J Kenneth Baillie; Atsushi Kobayashi; David S Donaldson; Hitoshi Ohmori; Sun-Ok Yoon; Arnold S Freedman; Tom C Freeman; Kim M Summers
Journal:  Immunology       Date:  2011-06-03       Impact factor: 7.397

Review 5.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

6.  LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis.

Authors:  John T Melchior; Janet K Sawyer; Kathryn L Kelley; Ramesh Shah; Martha D Wilson; Roy R Hantgan; Lawrence L Rudel
Journal:  J Lipid Res       Date:  2013-06-26       Impact factor: 5.922

7.  PRELP protein inhibits the formation of the complement membrane attack complex.

Authors:  Kaisa E Happonen; Camilla Melin Fürst; Tore Saxne; Dick Heinegård; Anna M Blom
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

Review 8.  Small leucine-rich repeat proteoglycans in corneal inflammation and wound healing.

Authors:  Jihane Frikeche; George Maiti; Shukti Chakravarti
Journal:  Exp Eye Res       Date:  2016-08-26       Impact factor: 3.467

Review 9.  New concepts of complement in allorecognition and graft rejection.

Authors:  Barbara A Wasowska; Chih-Yuan Lee; Marc K Halushka; William M Baldwin
Journal:  Cell Immunol       Date:  2007-10-24       Impact factor: 4.868

10.  Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice.

Authors:  S Nuka; W Zhou; S P Henry; C M Gendron; J B Schultz; T Shinomura; J Johnson; Y Wang; D R Keene; R Ramírez-Solis; R R Behringer; M F Young; M Höök
Journal:  Osteoarthritis Cartilage       Date:  2009-11-18       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.